ADHD: Drugs

Summary

To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the adequacy of the global supply of (a) Methylphenidate, (b) Lisdexamfetamine, (c) Guanfacine and (d) other Attention Deficit Hyperactivity Disorder medicati

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 19 December 2023

   Written question

   To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the adequacy of the global supply of (a) Methylphenidate, (b) Lisdexamfetamine, (c) Guanfacine and (d) other Attention Deficit Hyperactivity Disorder medicati

   Source: Commons

2. 8 January 2024

   Answer

   Shortages of medicines for attention deficit hyperactivity disorder (ADHD) including methylphenidate, lisdexamfetamine, and guanfacine have primarily been driven by regulatory issues at key manufacturing sites and capacity constraints at third party manuf...

   Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

• · Department of Health and Social Care · Answering body

Related records

No cross-record relationships stored yet.